Low concentrations of α-lipoic acid reduce palmitic acid-induced alterations in murine hypertrophic adipocytes

References

• Akbari M, Ostadmohammadi V, Tabrizi R, Mobini M, Lankarani KB, Moosazadeh M, Heydari ST, Chamani M, Kolahdooz F, Asemi Z. 2018. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab (Lond). 15:39.
   PubMed Web of Science ®Google Scholar
• Ambele MA, Dhanraj P, Giles R, Pepper MS. 2020. Adipogenesis: a complex interplay of multiple molecular determinants and pathways. Int J Mol Sci. 21(12):4283.
   PubMed Web of Science ®Google Scholar
• Cho KJ, Moon HE, Moini H, Packer L, Yoon DY, Chung AS. 2003. Alpha-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways. J Biol Chem. 278(37):34823–34833.
   PubMed Web of Science ®Google Scholar
• Cooke AA, Connaughton RM, Lyons CL, McMorrow AM, Roche HM. 2016. Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome. Eur J Pharmacol. 785:207–214.
   PubMed Web of Science ®Google Scholar
• Dajnowicz BP, Żebrowska E, Maciejczyk M, Zalewska A, Chabowski A. 2022. The effect of α-lipoic acid on oxidative stress in adipose tissue of rats with obesity-induced insulin resistance. Cell Physiol Biochem. 56(3):239–253.
   PubMedGoogle Scholar
• Engin A. 2017. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 960:1–17.
   PubMed Web of Science ®Google Scholar
• Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, Klip A. 1996. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes. 45(12):1798–1804.
   PubMed Web of Science ®Google Scholar
• Fernández-Galilea M, Pérez-Matute P, Prieto-Hontoria PL, Martinez JA, Moreno-Aliaga MJ. 2012. Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes. J Lipid Res. 53(11):2296–2306.
   PubMed Web of Science ®Google Scholar
• Fratantonio D, Speciale A, Molonia MS, Bashllari R, Palumbo M, Saija A, Cimino F, Monastra G, Virgili F. 2018. Alpha-lipoic acid, but not di-hydrolipoic acid, activates Nrf2 response in primary human umbilical-vein endothelial cells and protects against TNF-alpha induced endothelium dysfunction. Arch Biochem Biophys. 655:18–25.
   PubMed Web of Science ®Google Scholar
• Furuhashi M, Saitoh S, Shimamoto K, Miura T. 2014. Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol. 8(Suppl 3):23–33.
   PubMedGoogle Scholar
• Guria S, Hoory A, Das S, Chattopadhyay D, Mukherjee S. 2023. Adipose tissue macrophages and their role in obesity-associated insulin resistance: an overview of the complex dynamics at play. Biosci Rep. 43(3):BSR20220200.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. 2014. Regulation of NF-kappaB by TNF family cytokines. Semin Immunol. 26(3):253–266.
   PubMed Web of Science ®Google Scholar
• Hennig P, Garstkiewicz M, Grossi S, Di Filippo M, French LE, Beer HD. 2018. The crosstalk between Nrf2 and inflammasomes. Int J Mol Sci. 19(2):562.
   PubMed Web of Science ®Google Scholar
• Herman MA, Kahn BB. 2006. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest. 116(7):1767–1775.
   PubMed Web of Science ®Google Scholar
• Hermann R, Niebch G, Borbe HO, Fieger-Büschges H, Ruus P, Nowak H, Riethmüller-Winzen H, Peukert M, Blume H. 1996. Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. Eur J Pharm Sci. 4(3):167–174.
   Web of Science ®Google Scholar
• Huerta AE, Prieto-Hontoria PL, Sáinz N, Martínez JA, Moreno-Aliaga MJ. 2015. Supplementation with α-lipoic acid alone or in combination with eicosapentaenoic acid modulates the inflammatory status of healthy overweight or obese women consuming an energy-restricted diet. J Nutr. 146(4):889s–896s.
   PubMed Web of Science ®Google Scholar
• Kajita K, Mune T, Ikeda T, Matsumoto M, Uno Y, Sugiyama C, Matsubara K, Morita H, Takemura M, Seishima M, et al. 2008. Effect of fasting on PPARgamma and AMPK activity in adipocytes. Diabetes Res Clin Pract. 81(2):144–149.
   PubMed Web of Science ®Google Scholar
• Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, et al. 2004. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med. 10(7):727–733.
   PubMed Web of Science ®Google Scholar
• Kozka IJ, Clark AE, Holman GD. 1991. Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes. J Biol Chem. 266(18):11726–11731.
   PubMed Web of Science ®Google Scholar
• Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, Beguinot F, Miele C. 2019. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 20(9):2358.
   PubMed Web of Science ®Google Scholar
• Martin KA, Mani MV, Mani A. 2015. New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol. 763(Pt A):64–74.
   PubMedGoogle Scholar
• McCarty MF, DiNicolantonio JJ, O’Keefe JH. 2022. Nutraceutical prevention of diabetic complications-focus on dicarbonyl and oxidative stress. Curr Issues Mol Biol. 44(9):4314–4338.
   PubMed Web of Science ®Google Scholar
• Moini H, Packer L, Saris NE. 2002. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol. 182(1):84–90.
   PubMed Web of Science ®Google Scholar
• Moini H, Tirosh O, Park YC, Cho KJ, Packer L. 2002. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch Biochem Biophys. 397(2):384–391.
   PubMed Web of Science ®Google Scholar
• Molonia MS, Occhiuto C, Muscarà C, Speciale A, Bashllari R, Villarroya F, Saija A, Cimino F, Cristani M. 2020. Cyanidin-3-O-glucoside restores insulin signaling and reduces inflammation in hypertrophic adipocytes. Arch Biochem Biophys. 691(691):108488.
   PubMedGoogle Scholar
• Moreno-Vedia J, Girona J, Ibarretxe D, Masana L, Rodríguez-Calvo R. 2022. Unveiling the role of the fatty acid binding protein 4 in the metabolic-associated fatty liver disease. Biomedicines. 10(1):197.
   PubMed Web of Science ®Google Scholar
• Muscarà C, Molonia MS, Speciale A, Bashllari R, Cimino F, Occhiuto C, Saija A, Cristani M. 2019. Anthocyanins ameliorate palmitate-induced inflammation and insulin resistance in 3T3-L1 adipocytes. Phytother Res. 33(7):1888–1897.
   PubMed Web of Science ®Google Scholar
• Nandipati KC, Subramanian S, Agrawal DK. 2017. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance. Mol Cell Biochem. 426(1-2):27–45.
   PubMed Web of Science ®Google Scholar
• Packer L, Cadenas E. 2011. Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. J Clin Biochem Nutr. 48(1):26–32.
   PubMed Web of Science ®Google Scholar
• Paniagua JA. 2016. Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. World J Diabetes. 7(19):483–514.
   PubMed Web of Science ®Google Scholar
• Pérez-Torres I, Castrejón-Téllez V, Soto ME, Rubio-Ruiz ME, Manzano-Pech L, Guarner-Lans V. 2021. Oxidative stress, plant natural antioxidants, and obesity. Int J Mol Sci. 22(4):1786.
   PubMed Web of Science ®Google Scholar
• Rochette L, Ghibu S, Muresan A, Vergely C. 2015. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol. 93(12):1021–1027.
   PubMed Web of Science ®Google Scholar
• Rudich A, Tirosh A, Potashnik R, Khamaisi M, Bashan N. 1999. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia. 42(8):949–957.
   PubMed Web of Science ®Google Scholar
• Salehi B, Berkay Yılmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, Akram M, Riaz M, Capanoglu E, Sharopov F, et al. 2019. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. Biomolecules. 9(8):356.
   PubMed Web of Science ®Google Scholar
• Shay KP, Moreau RF, Smith EJ, Hagen TM. 2008. Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life. 60(6):362–367.
   PubMed Web of Science ®Google Scholar
• Speciale A, Saija A, Bashllari R, Molonia MS, Muscarà C, Occhiuto C, Cimino F, Cristani M. 2020. Anthocyanins as modulators of cell redox-dependent pathways in non-communicable diseases. Curr Med Chem. 27(12):1955–1996.
   PubMed Web of Science ®Google Scholar
• Spiller S, Blüher M, Hoffmann R. 2018. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus. Diabetes Obes Metab. 20(11):2661–2669.
   PubMed Web of Science ®Google Scholar
• Strauss RS. 1999. Comparison of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey. J Pediatr. 134(2):160–165.
   PubMed Web of Science ®Google Scholar
• Tibullo D, Li Volti G, Giallongo C, Grasso S, Tomassoni D, Anfuso CD, Lupo G, Amenta F, Avola R, Bramanti V. 2017. Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential. Inflamm Res. 66(11):947–959.
   PubMed Web of Science ®Google Scholar
• Valdecantos MP, Prieto-Hontoria PL, Pardo V, Módol T, Santamaría B, Weber M, Herrero L, Serra D, Muntané J, Cuadrado A, et al. 2015. Essential role of Nrf2 in the protective effect of ­lipoic acid against lipoapoptosis in hepatocytes. Free Radic Biol Med. 84:263–278.
   PubMed Web of Science ®Google Scholar
• Wardyn JD, Ponsford AH, Sanderson CM. 2015. Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans. 43(4):621–626.
   PubMed Web of Science ®Google Scholar
• Wołosowicz M, Dajnowicz-Brzezik P, Łukaszuk B, Żebrowska E, Maciejczyk M, Zalewska A, Kasacka I, Chabowski A. 2022. Diverse impact of N-acetylcysteine or alpha-lipoic acid supplementation during high-fat diet regime on fatty acid transporters in visceral and subcutaneous adipose tissue. Adv Med Sci. 67(2):216–228.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li W, Liu Y, Li Y, Gao L, Zhao JJ. 2014. Alpha-lipoic acid attenuates insulin resistance and improves glucose metabolism in high fat diet-fed mice. Acta Pharmacol Sin. 35(10):1285–1292.
   PubMed Web of Science ®Google Scholar
• Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. 2000. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia. 43(3):294–303.
   PubMed Web of Science ®Google Scholar
• Ying Z, Kampfrath T, Sun Q, Parthasarathy S, Rajagopalan S. 2011. Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function. Inflamm Res. 60(3):219–225.
   PubMed Web of Science ®Google Scholar
• Zhang WJ, Frei B. 2001. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. Faseb J. 15(13):2423–2432.
   PubMed Web of Science ®Google Scholar
• Zhou H, Urso CJ, Jadeja V. 2020. Saturated fatty acids in obesity-associated inflammation. J Inflamm Res. 13:1–14.
   PubMed Web of Science ®Google Scholar